Clinical Trials
15 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT06904365 2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT00867464 2026-03-03
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
National Cancer Institute (NCI)
Active not recruiting
NCT06236464 2025-07-29
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
National Cancer Institute, Naples
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT02379039 2023-12-22
MORRIS
Umeå University
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT00836992 2017-05-24
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Mayo Clinic
Completed
NCT00900302 2016-02-10
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT01379872 2013-02-13
ANROTAT
Trans Tasman Radiation Oncology Group
Completed